ACTU insider buying
Every open-market purchase of Actuate Therapeutics, Inc. (ACTU) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$50K
Insiders buying (12m)1
Purchases on record1
Last purchase filedOct 29, 2026
In the last 12 months, 1 insider of Actuate Therapeutics, Inc. bought $50K of ACTU stock on the open market in 1 reported purchase. The most recent was filed on Oct 29, 2026: Schmitt Daniel M (President, CEO and Director, Director) bought 140,844 shares at $0.35, worth $50K.
Get the next ACTU insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll ACTU insider purchases
| Filed | Insider | Value | Shares | Price | Stake | Trade | |
|---|---|---|---|---|---|---|---|
| Oct 29 | Schmitt Daniel MPresident, CEO and Director, Dire… | $50K | 140,844 | $0.35 | +47% | Oct 28 | SEC |